Literature DB >> 33957720

Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study.

Mehmet Sinan Dal, Naim Ata, Fevzi Altuntaş, Semih Başci, Tuğçe Nur Yiğenoğlu, Serdal Korkmaz, Sinem Namdaroğlu, Abdulkadir Baştürk, Tuba Hacibekiroğlu, Mehmet Hilmi Doğu, Ilhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Murat Çağlayan, Ersan Imrat, Osman Çelik, Mustafa Mahir Ülgü, Şuayip Birinci.   

Abstract

BACKGROUND/AIM: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 was inhibited by anti-A antibodies. The aim of the study was to investigate the relationship between blood groups and the course of COVID-19 in Turkey.
MATERIALS AND METHODS: Laboratory confirmed COVID-19 patients aged 18 and over (n=39.850) were randomized in age and gender-matched groups according to blood groups
Results: Advanced age, male gender and blood group A were found to be related with increased rate of intensive care unit (ICU) admission (OR =1.089, 95% CI: 1.085-1.093 for age; OR=1.963, 95% CI: 1.737-2.218 for male gender; OR=1.216, 95% CI: 1.023-1.446 for blood group A). When blood group O individuals were compared to non-O individuals, no significant difference was observed regarding the rate of hospital and ICU admission, mechanical ventilation (MV) support, length of hospital and ICU stay, and case fatality rate (CFR). The CFR in patients with blood group A, B, O, and AB were 2.6%, 2.2%, 3.1%, and 2.3%, respectively. There were no significant differences between Rh-negative and positive patients regarding the rate of hospital and ICU admission (p=0.280 and p=0.741, respectively), also the rate of MV support and CFR was similar (p=0.933 and p= 0.417).
CONCLUSION: Our study revealed that ABO and Rh blood groups do not have any impact on the rate of hospital admission, hospital and ICU stay, MV support, and CFR.

Entities:  

Keywords:  Blood Groups; COVID-19; SARS-CoV-2

Year:  2021        PMID: 33957720     DOI: 10.3906/sag-2101-321

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  2 in total

1.  Predictors of COVID-19 severity and hospitalization: A survey-based study from Jordan.

Authors:  Hassan M Kofahi; Samer F Swedan; Omar F Khabour; Refat M Nimer
Journal:  Inform Med Unlocked       Date:  2022-06-14

2.  Blood-Type-A Is A COVID-19 Infection And Hospitalization Risk In A Turkish Cohort.

Authors:  Meryem Cetin; Sirin Cetin; Ayse Ulgen; Wentian Li
Journal:  Transfus Clin Biol       Date:  2022-10-12       Impact factor: 2.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.